72831-89-1 Usage
Uses
Used in Pharmaceutical Development:
3-(piperidin-4-yl)indolin-2-one is utilized as a promising candidate in the development of novel pharmaceutical agents. Its unique chemical structure positions it as a potential drug target for the treatment of various diseases, particularly those with unmet medical needs.
Used in Medicinal Chemistry Research:
In the realm of medicinal chemistry, 3-(piperidin-4-yl)indolin-2-one serves as a valuable compound for studying its interactions with biological targets. This research can lead to a better understanding of its mechanisms of action and potential applications in therapeutic interventions.
Used in Drug Design:
3-(piperidin-4-yl)indolin-2-one is employed in drug design to create new molecules with improved pharmacological properties. Its structural features can be modified to enhance specificity, potency, and safety, making it a versatile building block for the development of innovative therapeutic agents.
Used in Cancer Therapy:
3-(piperidin-4-yl)indolin-2-one is used as a potential anticancer agent, given its interest in medicinal chemistry. It may be developed to target specific cancer-related pathways or to enhance the effectiveness of existing treatments, offering new hope for patients with cancer.
Used in Neurological Disorder Treatment:
3-(piperidin-4-yl)indolin-2-one is also considered for use in the treatment of neurological disorders. Its potential biological activities suggest that it could be a valuable asset in developing new therapies for conditions such as Alzheimer's, Parkinson's, or other neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 72831-89-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,8,3 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 72831-89:
(7*7)+(6*2)+(5*8)+(4*3)+(3*1)+(2*8)+(1*9)=141
141 % 10 = 1
So 72831-89-1 is a valid CAS Registry Number.
72831-89-1Relevant academic research and scientific papers
HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME
-
Paragraph 0755; 0758-0759, (2022/03/07)
A heterocyclic compound represented by formula XI, a pharmaceutically acceptable salt, a solvate, or a solvate of a pharmaceutically acceptable salt thereof, use thereof, and a composition containing the same. The compound is novel in structure and has good STAT5 inhibitory activity.
Synthesis of new bridged tetrahydro-β-carbolines and spiro-fused quinuclidines
Burm, Brigitte E.A,Gremmen, Christiaan,Wanner, Martin J,Koomen, Gerrit-Jan
, p. 2039 - 2049 (2007/10/03)
Two series of chemically related, conformationally restricted ring systems were synthesized. Bridged tetrahydro-β-carbolines, designed as selective 5-HT receptor ligands, were formed via Pictet-Spengler condensation of cyclic tryptamine precursors. Oxidation of the indole 2-position of the precursors followed by condensation with aldehydes produced spiro-cyclic quinuclidines, containing important muscarine receptor pharmacophores.
Antihypertensive 2H-indol-2-ones
-
, (2008/06/13)
Novel optically active isomers or racemates of 1,3-dihydro-3-{1-[2-(2,3-dihydro-1,4-benzodioxin-2-yl)-2-hydroxyethyl]-piperidin-4-yl}-2H-indol-2-ones of the formula STR1 wherein R1 is selected from the group consisting of hydrogen, chlorine, bromine, fluorine and alkoxy of 1 to 5 carbon atoms and R2 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having antihypertensive activity and a novel process and intermediates for their preparation.
